Top Gish Official Buys Shares in Company
- Share via
Dow Jones
Gish Biomedical Inc. Chief Executive Kelly D. Scott bought 65,000 shares of the company’s common stock in June, about a month after joining the Irvine maker of disposable medical devices, according to a report filed Monday with the Securities and Exchange Commission.
Scott bought the stock June 13 and 14 at prices ranging from $2.19 to $2.50 a share. The stock closed Monday at $2.47, up 3 cents a share, in Nasdaq trading.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
